Stockscreener 앱 받기
1.06
7.83%
-0.09
Fibrobiologics Inc 주식(FBLG)의 최신 뉴스
Armistice Capital discloses 9.99% FibroBiologics (FBLG) stake via Master Fund - Stock Titan
FibroBiologics Inc - Smartkarma
FibroBiologics receives patent for islet transplant method By Investing.com - Investing.com UK
FibroBiologics Patent Could Help Stretch Scarce Donor Pancreases - Stock Titan
Fibrobiologics Inc (FBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Fibrobiologics Inc (FBLG) Stock News Today - tradingkey.com
FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage - morningstar.com
FibroBiologics patent covers Sox9 turning fibroblasts into cartilage cells - Stock Titan
H.C. Wainwright cuts FibroBiologics price target to $6 on model adjustments - Investing.com
FibroBiologics Q2 EPS beats estimates as losses narrow 72.5% - scanx.trade
FibroBiologics, Inc. Revenue Breakdown – NASDAQ:FBLG - TradingView
FBLG: Advanced clinical pipeline, reduced R&D costs, raised $12M, and expanded patent assets - tradingview.com
FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate - PR Newswire
FIBROBIOLOGICS ($FBLG) Releases Q2 2026 Earnings - Quiver Quantitative
FibroBiologics, Inc. 2Q 2026: Net loss $(4.12M), EPS $(0.66) — 10-Q Summary - TradingView
FibroBiologics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Form DEF 14A FIBROBIOLOGICS For: 31 July By Investing.com - Investing.com Nigeria
FBLG Q2'26 Earnings: EPS estimate is (0.93) USD - TradingView
Fibrobiologics Inc (FBLG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Fibrobiologics Inc (FBLG) Valuation: PE, PB & Fair Value Analysis - TradingKey
FBLG|Fibrobiologics Inc|Price:0.681|Chg%:-0.031 - TradingKey
Fibrobiologics Inc (FBLG) Institutional Confidence - TradingKey
Fibrobiologics Inc (FBLG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Fibrobiologics Inc expected to post a loss of 72 cents a shareEarnings Preview - TradingView
Fibrobiologics Inc (FBLG) Balance Sheet - TradingKey
FBLG|Fibrobiologics Inc|Price:0.712|Chg%:-0.024 - TradingKey
FibroBiologics Market Sentiment - Benzinga España
Fibrobiologics Inc (FBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Fibrobiologics Inc (FBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Fibrobiologics Inc (FBLG) Earnings Date & Reports & Earnings News - tradingkey.com
FBLG|Fibrobiologics Inc|Price:1.020|Chg%:+0.152 - TradingKey
TradingKey - TradingKey
FibroBiologics Faces Nasdaq Delisting, Appeals Planned - TipRanks
FibroBiologics Received Notice of Delisting - TradingView
FibroBiologics (NASDAQ: FBLG) appeals Nasdaq move to delist its shares - Stock Titan
FibroBiologics (FBLG) Q4 2025 earnings summary - Quartr
FibroBiologics (FBLG) Registration filing Summary - Quartr
FibroBiologics (FBLG) Proxy filing Summary - Quartr
FibroBiologics (FBLG) AGM 2026 Summary - Quartr
FBLG Q2'26 Earnings: revenue estimate is 0 USD - TradingView
FibroBiologics Inc. (FBLG) Q1 2026 Earnings: Slight EPS Miss as Pre-Revenue Biotech Advances PipelineCore Business Growth - dars.gov.et
Form PRE 14A FIBROBIOLOGICS For: 17 July By Investing.com - Investing.com Nigeria
FibroBiologics (NASDAQ: FBLG) puts large warrant share issuance to a stockholder vote - Stock Titan
FibroBiologics, Inc. SEC Filing (Jul 17, 2026) - Stock Titan
FibroBiologics (Nasdaq: FBLG) files to register 12.53M warrant shares - Stock Titan
FibroBiologics director Kathleen Hallisey Rubins files initial beneficial ownership statement - Bitget
FibroBiologics Inc. (FBLG) Q1 2026 Earnings: Pre-Revenue Biotech Reports Slight EPS Miss as Stock Declines - dars.gov.et
FBLG Q1 2026 Earnings: EPS Slightly Misses Estimates as Pre-Revenue Biotech Continues R&D FocusNon-GAAP Earnings - dars.gov.et
Daily Brief Health Care: Centene Corp, FibroBiologics, Molina Healthcare, Solvonis Therapeutics and more - Smartkarma
Daily Brief United States: Apple, BlackRock, Sunrun Inc, Crude Oil, Culp Inc, Cna Financial, FibroBiologics, F&G Annuities & Life , Getty Images Holdings , Cincinnati Financial and more - Smartkarma
FibroBiologics Appoints NASA Scientist Kate Rubins to Board - The Globe and Mail
Form S-3 Fibrobiologics Inc For: 10 July By Investing.com - Investing.com South Africa
Form S-3 Fibrobiologics Inc For: 10 July - Investing.com India
FibroBiologics, Inc. (NASDAQ: FBLG) registers up to 12.53M shares for resale by selling holders - Stock Titan
0.52%
0.07%
자본화:
|
볼륨(24시간):